How does graphene in the vaccines fight the virus? Graphene vaccine patents versus the Corona virus patents
Take the graphene vaccine patents and compare them to all the virus patterns do you see a truly for real life-saving event happening or is it all just smoking mirrors?
Here Is What Your "Trusted Truthers" Will Never Tell You About CORONA-'VIRUS' & JABS! The viruses are actually sensors AI nanobots THE TRUTH ONLY SPREADS IF YOU SHARE IT! https://rumble.com/v4hiea0-march-5-2024.html Hyu CORONA: A Coordinate and Routing system for
Nanonetworks https://users.ics.forth.gr/~cliaskos/files/cnf/NANOCOM15.pdf Energy-efficient route of wireless sensor network
Abstract
The invention provides an energy-efficient routing algorithm (MEERP) for a wireless sensor network, and belongs to the technical field of the wireless sensor network application. This algorithm introduces a mobile sink node and a mobile relay node, considers a size of the network and a quantity of the nodes, and divides the network into several square areas; and then according to a weight sum of node residual energy and a cluster barycentric coordinate distance, a cluster head is selected. The nodes in a grid is communicated with a cluster head node through a multi-hop manner; a controllable mobile strategy is used for the mobile sink node, and when the mobile sink node moves to near the cluster head node, the cluster head node directly sends collected data to the mobile sink node; and a regular mobile manner is used for the mobile relay node in the network, and when the mobile relay node moves to a same position as a sensor node, the mobile relay node takes a forwarding task of all packets of the sensor node, but the sensor node only sends data which are sensed by the sensor node. This algorithm is mainly used in the wireless sensor network route control field.
Images (4)
Classifications
Y02D30/00 Reducing energy consumption in communication networks
View 1 more classifications
CN103619049A Electromagnetic Nanocommunication Networks:
Principles, Applications, and Challenges https://ieeexplore.ieee.org/ielx7/6287639/9312710/09648301.pdf?tp=&arnumber=9648301&isnumber=9312710&ref=
To start Let's take a look at University of chapel Hill Patent method for producing recombinant coronavirus 7279327 Yes it contains graphene oxidein 2002 This application claims priority under 35 U.S.C. § 371 from PCT Application No. PCT/US02/12453, filed in English on Apr. 19, 2002, which claims the benefit of U.S. Application Ser. No. 60/285,320 and U.S. Application Ser. No. 60/285,318, both filed on Apr. 20, 2001, the disclosures and contents of which are incorporated by reference herein in their entireties. Methods for Producing Recombinant Coronavirus," April 19 2002. 👈
"STATEMENT OF FEDERAL SUPPORT 👇👇
This invention was made possible with government support under grant numbers AI23946 and GM63228 from the National Institutes of Health. The United States government has certain rights to this invention."
"FIELD OF THE INVENTION
The present invention relates to methods of producing recombinant nidovirus vectors, particularly coronavirus vectors, and expressing heterologous genes from said vectors."
Patent History
Patent number: 7279327
Type: Grant
Filed: Apr 19, 2002
Date of Patent: Oct 9, 2007
Patent Publication Number: 20040235132
Assignee: The University of North Carolina at Chapel Hill (Chapel Hill, NC)
Inventors: Kristopher M. Curtis (Chapel Hill, NC), Boyd Yount (Hillsborough, NC), Ralph S. Baric (Haw River, NC)
Primary Examiner: Bruce R. Campell
Assistant Examiner: Bao Quh Li
Attorney: Myers, Bigel, Sibley & Sajovec, P.A.
Application Number: 10/474,962
Classifications
Current U.S. Class: Animal Cell, Per Se (e.g., Cell Lines, Etc.); Composition Thereof; Process Of Propagating, Maintaining Or Preserving An Animal Cell Or Composition Thereof; Process Of Isolating Or Separating An Animal Cell Or Composition Thereof; Process Of Preparing A Composition Containing An Animal Cell; Culture Media Therefore (435/325); Vector, Per Se (e.g., Plasmid, Hybrid Plasmid, Cosmid, Viral Vector, Bacteriophage Vector, Etc.) Bacteriophage Vector, Etc.) (435/320.1); Coronaviridae (e.g., Neonatal Calf Diarrhea Virus, Feline Infectious Peritonitis Virus, Canine Coronavirus, Etc.) (424/221.1)
International Classification: C12N 15/85 (20060101); C12N 15/63 (20060101); STATEMENT OF PRIORITY
This application is a 35 U.S.C. §371 national phase application of International Application Serial No. PCT/US2015/021773, filed Mar. 20, 2015, which claims the benefit, under 35 U.S.C. § 119(e), of U.S. Provisional Application Ser. No. 61/968,279, filed Mar. 20, 2014, the entire content of each of which is incorporated by reference herein.
STATEMENT OF FEDERAL SUPPORT
This invention was made with government support under Grant No. U54AI057157 awarded by the National Institutes of Health. The government has certain rights in the invention. https://www.youtube.com/live/BhYpi9cRenY?si=slH10_1s22eTpUYZ
STATEMENT REGARDING ELECTRONIC FILING OF A SEQUENCE LISTING
A Sequence Listing in ASCII text format, submitted under 37 C.F.R. § 1.821, entitled 5470-672_ST25.txt, 90,897 bytes in size, generated on Dec. 9, 2016 and filed via EFS-Web, is provided in lieu of a paper copy. This Sequence Listing is hereby incorporated by reference into the specification for its disclosures. Methods and compositions for chimeric coronavirus spike proteins
Abstract
The present invention provides compositions and methods comprising a chimeric coronavirus spike protein.
Classifications
C07K14/005 Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
US9884895B2
THE RACE TO PATENT THE SARS VIRUS:
THE TRIPS AGREEMENT AND ACCESS TO ESSENTIAL
MEDICINES https://law.unimelb.edu.au/__data/assets/pdf_file/0007/1681117/Rimmer.pdf So what other vaccines contain graphene oxide? Let's take a look finding that graphene oxide/silver nanoparticle ink can rapidly prevent in vitro infection with two different viruses it suggests that the ink has the potential to be used in a variety of applications to help reduce the spread of viruses in the environment,” Dr. Meredith J. Crane, co-author of the research, published on the bioRxiv*preprint server, said. And then there's this NKJET-PRINTED FLEXIBLE ELECTRONIC COMPONENTS FROM GRAPHENE OXIDE
Publication number: 20140334065 Publication date: November 13, 2014
Applicants: THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY, GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY
INKJET-PRINTED FLEXIBLE ELECTRONIC COMPONENTS FROM GRAPHENE OXIDE
Publication number: 20140321028 Publication date: October 30, 2014
Applicants: THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY, GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY
Epitaxial Graphene Surface Preparation for Atomic Layer Deposition of Dielectrics
Publication number: 20140308437 Filed: June 26, 2014
Publication date: October 16, 2014
Applicant: The Government of the United States of America, as represented by the Secretary of the Navy
Graphene nanoplatelet and graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-2 https://www.sciencedirect.com/science/article/pii/S2589004221007562
Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: Engineering a recombination-resistant genome https://www.pnas.org/doi/10.1073/pnas.0605438103
And for the deep dive session
https://patents.google.com/?q=A61K2039%2f55555
https://patents.google.com/?q=A61P35%2f00
https://patents.google.com/?q=A61K47%2f59
https://patents.google.com/?q=A61K2039%2f55561
https://patents.google.com/?q=B82Y30%2f00
https://patents.google.com/?q=B82Y5%2f00
https://patents.google.com/?q=A61K2039%2f53 https://patents.google.com/?q=A61K2039%2f52 https://patents.google.com/?q=C12N15%2f86
http://www.google.com/patents/sitemap/en/Sitemap/A61/A61P.html US7618802B2 2009-11-17 Compositions of coronaviruses with a recombination-resistant genome
Curtis et al. 2002 Heterologous gene expression from transmissible gastroenteritis virus replicon particles
JP4130729B2 2008-08-06 North American swine reproductive and respiratory syndrome (PRRS) virus infectious cDNA clones and uses thereof
US8609827B2 2013-12-17 Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
EP1736539A1 2006-12-27 Attenuated SARS-CoV vaccines
Fang et al. 2007 An arginine-to-proline mutation in a domain with undefined functions within the helicase protein (Nsp13) is lethal to the coronavirus infectious bronchitis virus in cultured cells
KR100916883B1 2009-09-09 Chimeric arterivirus-like particles
WO2018090994A1 2018-05-24 Temperature-sensitive attenuating strain of foot-and-mouth disease virus, construction method therefor and uses thereof
WO2007062851A2 2007-06-07 Nucleic acids encoding tgev and prrsv sequences for improved expression of prrsv sequences
NZ529691A 2007-12-21 Coronaviruses and diagnosis, therapeutic use and vaccines derived thereof.
WO2005035556A2 2005-04-21 Sars-coronavirus virus-like particles and methods of use
CZ302785B6 2011-11-09 Method of preparing DNA derived from coronavirus, corresponding infective clones, vectors and vaccines
US20060171962A1 2006-08-03 SARS vaccine
Li et al. 2022 The N1038S Substitution and 1153EQTRPKKSV1162 Deletion of the S2 Subunit of QX-Type Avian Infectious Bronchitis Virus Can Synergistically Enhance Viral Proliferation
JP4664072B2 2011-04-06 Pestivirus replicons that do not express C and / or E1 protein and infectious viral particles comprising said replicons that can be used in vaccines
US7279327B2 2007-10-09 Methods for producing recombinant coronavirus
Becares et al. 2014 Antigenic structures stably expressed by recombinant TGEV-derived vectors
JP4937460B2 2012-05-23 Pestivirus mutant and vaccine containing the same
LT et al. 0 INVESTIGACIONES CIENTIFICAS
Enjuanes Sánchez et al. 2006 Attenuated Sars and use as a Vaccine
JP2023531123A 2023-07-21 Particles, DNA and RNA
Deming 2007 Genetic approaches to the study of coronavirus replication and pathogenesis
Ortego Alonso et al. 2006 Nucleic acid sequences encoding proteins capable of associating into avirus-like particle
Curtis 2003 Reverse genetic analysis of TGEV gene function and replication
FENG 2005 Development and characterization of a SARS-coronavirus replicon cell line US10751410B2 2020-08-25 Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methods
US10548968B2 2020-02-04 Functional influenza virus-like particles (VLPS)
US10729760B2 2020-08-04 Functional influenza virus like particles (VLPs)
KR101691574B1 2017-01-02 Modified rsv f proteins and methods of their use
US10544399B2 2020-01-28 Highly efficient influenza matrix (M1) proteins
US20110008838A1 2011-01-13 Chimeric varicella zoster virus virus-like particles
NZ567164A 2012-06-29 Functional influenza virus like particles (VLPS)
AU2013201495A1 2013-04-18 Recombinant nanoparticle RSV F vaccine for respiratory syncytial virus
EP2953642A1 2015-12-16 Combination vaccine for respiratory syncytial virus and influenza
AU2011348160A1 2013-04-04 Modified influenza hemagglutinin proteins and uses thereof
WO2010148386A1 2010-12-23 Swine-origin influenza a (h1n1) virus-like particles and methods of use thereof KR1020177004614A 2014-07-23 2015-07-23 Coronavirus
DK15750093.5T 2014-07-23 2015-07-23 CORONA VIRUS
PL15750093T 2014-07-23 2015-07-23 Coronavirus
MX2016016722A 2014-07-23 2015-07-23 Coronavirus.
ES15750093T 2014-07-23 2015-07-23 Coronavirus
EP19208113.1A 2014-07-23 2015-07-23 Live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in nsp-10.
CA2953677A 2014-07-23 2015-07-23 Coronavirus
US15/328,179 2014-07-23 2015-07-23 Coronavirus
CN201580037402.1A 2014-07-23 2015-07-23 Coronavirus
EP15750093.5A 2014-07-23 2015-07-23 Coronavirus
JP2017524123A 2014-07-23 2015-07-23 Coronavirus
AU2015293633A 2014-07-23 2015-07-23 Coronavirus
IL249340A 2014-07-23 2016-12-01 Coronavirus
Great stuff! Shot in the heart of their psyco system. Keep up the good work! Feel like genetics professor nowdays but Greece knows...
Tnx a lot!
Good grief... I'm no genious here, but I don't think God intended us to have this synthetic black (no matter how fancy) goo circulating or (God forbid) recombining in our body... Thank you for the research and for letting us know what's in the book of lab created tax-funded chimeras, lining up to be added into the registry of human's outmost folly...